unknown
Stage
About
CollPlant develops recombinant human collagen (rhCollagen) technology and products for regenerative medicine, including 3D bioprinting bioinks, medical aesthetics such as dermal fillers and implants, and tissue regeneration therapies.
Explore CollPlant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.